Exhibit 99.1
NEWS RELEASE
Contact:
Alliance HealthCare Services
Howard Aihara
Executive Vice President
Chief Financial Officer
(949) 242-5300
ALLIANCE HEALTHCARE SERVICES REPORTS RESULTS
FOR THE FIRST QUARTER ENDED MARCH 31, 2010
AND REAFFIRMS FULL YEAR 2010 GUIDANCE
NEWPORT BEACH, CA—April 28, 2010—Alliance HealthCare Services, Inc. (NYSE:AIQ) (the “Company” or “Alliance”), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the first quarter ended March 31, 2010.
First Quarter 2010 Financial Results
Revenue for the first quarter of 2010 was $118.7 million compared to $131.8 million in the first quarter of 2009, a decrease of 10.0%. On a sequential quarter basis, revenue decreased 0.7% from $118.7 million in the first quarter of 2010 compared to $119.5 million in the fourth quarter of 2009.
Alliance’s Adjusted EBITDA (as defined below) was $40.2 million in the first quarter of 2010 compared to $47.8 million in the first quarter 2009, a decrease of 16.0%. On a sequential quarter basis, Adjusted EBITDA increased 5.1% from $40.2 million in the first quarter of 2010 compared to $38.2 million in the fourth quarter of 2009.
Earnings (loss) per share on a diluted basis, computed in accordance with generally accepted accounting principles (“GAAP”), were ($0.04) per share in the first quarter of 2010 and $0.08 per share in the first quarter of 2009. In the first quarter of 2010 earnings (loss) per share on a diluted basis were impacted by fair value adjustments related to interest rate swaps of ($0.01) per share, severance and related costs and mergers and acquisitions transaction costs of ($0.01) per share in the aggregate and ($0.01) per share due to a lower GAAP income tax rate than our historical income tax rate. Alliance’s historical income tax rate has been between 42% and 43%, specifically 42.2% in the first quarter of 2009, rather than the GAAP income tax benefit rate of 22.1% in the first quarter of 2010.
Alliance’s net loss, computed in accordance with GAAP, totaled ($2.2) million in the first quarter of 2010 compared to net income of $4.3 million in the first quarter of 2009.
Cash flows provided by operating activities were $30.7 million in the first quarter of 2010 compared to $32.9 million in the first quarter of 2009. Capital expenditures in the first quarter of 2010 were $20.2 million compared to $14.9 million in the first quarter of 2009. Alliance opened 4 new fixed-site imaging centers in the first quarter of 2010.
1
Alliance’s net debt, defined as total long-term debt (including current maturities) less cash and cash equivalents, decreased $10.2 million to $545.8 million at March 31, 2010 from $556.0 million at December 31, 2009. Cash and cash equivalents were $114.2 million at March 31, 2010 and $111.9 million at December 31, 2009. The Company’s net debt, as defined above, divided by the last twelve months Adjusted EBITDA, was 3.2x for the twelve month period ended March 31, 2010.
The Company’s total long-term debt (including current maturities) decreased to $660.0 million at March 31, 2010 from $667.9 million at December 31, 2009. The Company’s total debt divided by last twelve months Adjusted EBITDA was 3.8x for the twelve month period ended March 31, 2010.
Paul S. Viviano, Chairman of the Board and Chief Executive Officer, stated, “Alliance HealthCare Services first quarter performance reflects an improvement in profitability from fourth quarter 2009 levels. We are encouraged by the macroeconomic trends which appear to be stabilizing. We will continue to make investments in radiation oncology centers and fixed-site imaging centers in partnership with hospitals, and continue to pursue selective acquisitions.”
Full Year 2010 Guidance
Alliance is reaffirming its full year 2010 guidance ranges as follows:
| | Guidance Ranges | |
| | (Dollars in millions) | |
| | | |
Revenue | | $470 - $500 | |
Adjusted EBITDA | | $155 - $180 | |
Cash capital expenditures | | $65 - $75 | |
Decrease in long-term debt, net of the change in cash and cash equivalents (before acquisitions) | | $30 - $50 | |
Fixed-site imaging center openings | | 20 - 25 | |
Radiation oncology center openings | | 5 - 8 | |
First Quarter 2010 Earnings Conference Call
Investors and all others are invited to listen to a conference call discussing first quarter 2010 results. The conference call is scheduled for Thursday, April 29 at 8:30 a.m. Eastern Time. The call will be broadcast live on the Internet and can be accessed by visiting the Company’s website at www.alliancehealthcareservices-us.com. Click on Audio Presentations in the Investors section of the website to access the link.
The conference call can be accessed at (888) 694-4676 (United States) or (973) 582-2737 (International). Interested parties should call at least 5 minutes prior to the call to register. A telephone replay will be available until July 29, 2010. The telephone replay can be accessed by calling (800) 642-1687 (United States) or (706) 645-9291 (International). The conference call identification number is 71771669.
2
Definition of Adjusted EBITDA
Adjusted EBITDA, as defined by the Company’s management, represents net income before: interest expense, net of interest income; income taxes; depreciation expense; amortization expense; net income attributable to noncontrolling interests; non-cash share-based compensation; severance and related costs; loss on extinguishment of debt; fees and expenses related to acquisitions and other non-cash charges included in other income (expense), net, which includes non-cash losses on sales of equipment. The components used to reconcile net income to Adjusted EBITDA are consistent with our historical presentation of Adjusted EBITDA. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles, or “GAAP.” For a more detailed discussion of Adjusted EBITDA and reconciliation to net income, see the table entitled “Adjusted EBITDA” included in the tables following this release.
About Alliance HealthCare Services
Alliance HealthCare Services is a leading national provider of shared-service and fixed-site diagnostic imaging services, based upon annual revenue and number of diagnostic imaging systems deployed, and a provider of radiation therapy services. Alliance provides imaging and therapeutic services primarily to hospitals and other healthcare providers on a shared and full-time service basis, in addition to operating a growing number of fixed-site imaging and radiation therapy centers. The Company had 507 diagnostic imaging and radiation therapy systems, including 297 MRI systems and 125 PET or PET/CT systems, and served over 1,000 clients in 45 states at March 31, 2010. The Company operated 119 fixed-site imaging centers (three in unconsolidated joint ventures), which includes systems installed in hospitals or other buildings on or near hospital campuses, medical groups’ offices, or medical buildings and retail sites. The Company also operated 25 radiation therapy centers and stereotactic radiosurgery facilities (two radiation therapy centers are in unconsolidated joint ventures) as of March 31, 2010.
3
Forward-Looking Statements
This press release contains forward-looking statements relating to future events, including statements related to investment, development and acquisition activity, the implementation of strategic initiatives, the integration of acquired businesses into the Company, the opening of new imaging and radiation oncology centers, and the Company’s full year 2010 guidance. In this context, forward-looking statements often address the Company’s expected future business and financial results and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks” or “will.” Forward-looking statements by their nature address matters that are uncertain and subject to risks. Such uncertainties and risks include: changes in the preliminary financial results and estimates due to the restatement or review of the Company’s financial statements; the nature, timing and amount of any restatement or other adjustments; the Company’s ability to make timely filings of its required periodic reports under the Securities Exchange Act of 1934; issues relating to the Company’s ability to maintain effective internal control over financial reporting and disclosure controls and procedures; the Company’s high degree of leverage and its ability to service its debt; factors affecting the Company’s leverage, including interest rates; the risk that the counterparties to the Company’s interest rate swap agreements fail to satisfy their obligations under these agreements; the Company’s ability to obtain financing; the effect of operating and financial restrictions in the Company’s debt instruments; the accuracy of the Company’s estimates regarding its capital requirements; the effect of intense levels of competition in the Company’s industry; changes in the methods of third party reimbursements for diagnostic imaging and radiation oncology services; fluctuations or unpredictability of the Company’s revenues, including as a result of seasonality; changes in the healthcare regulatory environment; the Company’s ability to keep pace with technological developments within its industry; the growth in the market for MRI and other services; the disruptive effect of hurricanes and other natural disasters; adverse changes in general domestic and worldwide economic conditions and instability and disruption of credit markets; difficulties the Company may face in connection with recent, pending or future acquisitions, including unexpected costs or liabilities resulting from the acquisitions, diversion of management’s attention from the operation of the Company’s business, and risks associated with integration of the acquisitions; and other risks and uncertainties identified in the Risk Factors section of the Company’s Form 10-K for the year ended December 31, 2009, filed with the Securities and Exchange Commission (the “SEC”) as may be modified or supplemented by our subsequent filings with the SEC. These uncertainties may cause actual future results or outcomes to differ materially from those expressed in the Company’s forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake to update its forward-looking statements except as required under the federal securities laws.
###
4
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(Unaudited)
(in thousands, except per share amounts)
| | Quarter Ended | |
| | March 31, | |
| | 2009 | | 2010 | |
| | | | | |
Revenues | | $ | 131,788 | | $ | 118,661 | |
| | | | | |
Costs and expenses: | | | | | |
Cost of revenues, excluding depreciation and amortization | | 68,879 | | 65,226 | |
Selling, general and administrative expenses | | 17,893 | | 16,117 | |
Transaction costs | | 431 | | 351 | |
Severance and related costs | | 182 | | 462 | |
Depreciation expense | | 23,650 | | 23,691 | |
Amortization expense | | 2,776 | | 2,806 | |
Interest expense and other, net | | 10,677 | | 13,304 | |
Other (income) and expense, net | | (256 | ) | (360 | ) |
Total costs and expenses | | 124,232 | | 121,597 | |
| | | | | |
Income (loss) before income taxes, earnings from unconsolidated investees, and noncontrolling interest, net of tax | | 7,556 | | (2,936 | ) |
Income tax expense (benefit) | | 3,161 | | (613 | ) |
Earnings from unconsolidated investees | | (587 | ) | (907 | ) |
Net income (loss) | | 4,982 | | (1,416 | ) |
Less: Net income attributable to noncontrolling interest, net of tax | | (654 | ) | (747 | ) |
Net income (loss) attributable to Alliance HealthCare Services, Inc. | | $ | 4,328 | | $ | (2,163 | ) |
| | | | | |
Comprehensive income (loss), net of taxes: | | | | | |
Net income (loss) attributable to Alliance HealthCare Services, Inc. | | $ | 4,328 | | $ | (2,163 | ) |
Unrealized (loss) gain on hedging transactions, net of taxes | | (862 | ) | 495 | |
Comprehensive income (loss), net of taxes: | | $ | 3,466 | | $ | (1,668 | ) |
| | | | | |
Earnings (loss) per common share attributable to Alliance HealthCare Services, Inc.: | | | | | |
Basic | | $ | 0.08 | | $ | (0.04 | ) |
Diluted | | $ | 0.08 | | $ | (0.04 | ) |
| | | | | |
Weighted average number of shares of common stock and common stock equivalents: | | | | | |
Basic | | 51,651 | | 52,755 | |
Diluted | | 52,294 | | 52,755 | |
5
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
| | December 31, | | March 31, | |
| | 2009 | | 2010 | |
ASSETS | | | | | |
Current assets: | | | | | |
Cash and cash equivalents | | $ | 111,884 | | $ | 114,197 | |
Accounts receivable, net of allowance for doubtful accounts | | 61,912 | | 61,632 | |
Deferred income taxes | | 19,058 | | 19,058 | |
Prepaid expenses and other current assets | | 9,184 | | 8,833 | |
Other receivables | | 4,197 | | 3,471 | |
Total current assets | | 206,235 | | 207,191 | |
| | | | | |
Equipment, at cost | | 863,804 | | 874,213 | |
Less accumulated depreciation | | (523,748 | ) | (537,432 | ) |
Equipment, net | | 340,056 | | 336,781 | |
| | | | | |
Goodwill | | 194,243 | | 194,243 | |
Other intangible assets, net | | 100,188 | | 97,157 | |
Deferred financing costs, net | | 17,143 | | 16,651 | |
Other assets | | 29,971 | | 26,915 | |
Total assets | | $ | 887,836 | | $ | 878,938 | |
| | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | |
Current liabilities: | | | | | |
Accounts payable | | $ | 23,888 | | $ | 16,112 | |
Accrued compensation and related expenses | | 17,311 | | 18,038 | |
Accrued interest payable | | 3,789 | | 9,595 | |
Other accrued liabilities | | 32,887 | | 34,143 | |
Current portion of long-term debt | | 16,902 | | 10,978 | |
Total current liabilities | | 94,777 | | 88,866 | |
| | | | | |
Long-term debt, net of current portion | | 463,455 | | 461,460 | |
Senior notes | | 187,533 | | 187,600 | |
Other liabilities | | 3,737 | | 3,592 | |
Deferred income taxes | | 103,572 | | 103,145 | |
Total liabilities | | 853,074 | | 844,663 | |
| | | | | |
Stockholders’ equity: | | | | | |
Common stock | | 516 | | 523 | |
Treasury stock | | (2,333 | ) | (2,333 | ) |
Additional paid-in capital | | 10,652 | | 12,229 | |
Accumulated comprehensive loss | | (2,392 | ) | (1,897 | ) |
Retained earnings | | 21,477 | | 19,314 | |
Total stockholders’ equity attributable to Alliance HealthCare Services, Inc. | | 27,920 | | 27,836 | |
Noncontrolling interest | | 6,842 | | 6,439 | |
Total stockholders’ equity | | 34,762 | | 34,275 | |
Total liabilities and stockholders’ equity | | $ | 887,836 | | $ | 878,938 | |
6
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands)
| | Quarter Ended
March 31, | |
| | 2009 | | 2010 | |
Operating activities: | | | | | |
Net income (loss) | | $ | 4,982 | | $ | (1,416 | ) |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | |
Provision for doubtful accounts | | 466 | | (141 | ) |
Share-based payment | | 1,663 | | 1,520 | |
Depreciation and amortization | | 26,426 | | 26,497 | |
Amortization of deferred financing costs | | 580 | | 645 | |
Accretion of discount on long term debt | | 555 | | 378 | |
Adjustment of derivatives to fair value | | (635 | ) | (578 | ) |
Distributions greater than undistributed earnings from investees | | 65 | | 513 | |
Deferred income taxes | | 2,414 | | (772 | ) |
Excess tax benefit from share-based payment arrangements | | (7 | ) | — | |
Gain on sale of assets | | (362 | ) | (360 | ) |
Changes in operating assets and liabilities, net of acquisitions: | | | | | |
Accounts receivable | | (3,207 | ) | 421 | |
Prepaid expenses and other current assets | | 1,937 | | 351 | |
Other receivables | | (2,365 | ) | 726 | |
Other assets | | (4,481 | ) | 201 | |
Accounts payable | | (1,019 | ) | (4,788 | ) |
Accrued compensation and related expenses | | (654 | ) | 727 | |
Accrued interest payable | | 5,135 | | 5,806 | |
Income taxes payable | | 70 | | 50 | |
Other accrued liabilities | | 1,305 | | 871 | |
Other liabilities | | (1 | ) | — | |
Net cash provided by operating activities | | 32,867 | | 30,651 | |
| | | | | |
Investing activities: | | | | | |
Equipment purchases | | (14,891 | ) | (20,205 | ) |
(Increase) decrease in deposits on equipment | | (905 | ) | 553 | |
Acquisitions, net of cash received | | (580 | ) | — | |
Decrease in cash in escrow | | 2,075 | | — | |
Proceeds from sale of assets | | 2,348 | | 772 | |
Net cash used in investing activities | | (11,953 | ) | (18,880 | ) |
| | | | | | | |
7
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(Unaudited)
(in thousands)
| | Quarter Ended
March 31, | |
| | 2009 | | 2010 | |
| | | | | |
Financing activities: | | | | | |
Principal payments on equipment debt | | (2,207 | ) | (1,856 | ) |
Proceeds from equipment debt | | 415 | | 358 | |
Principal payments on term loan facility | | — | | (1,150 | ) |
Principal payments on senior subordinated notes | | — | | (5,582 | ) |
Payments of debt issuance costs | | (157 | ) | (153 | ) |
Noncontrolling interest in subsidiaries | | (1,210 | ) | (1,150 | ) |
Proceeds from shared-based payment arrangements | | 42 | | 75 | |
Excess tax benefit from share-based payment arrangements | | 7 | | — | |
Net cash used in financing activities | | (3,110 | ) | (9,458 | ) |
| | | | | |
Net increase in cash and cash equivalents | | 17,804 | | 2,313 | |
Cash and cash equivalents, beginning of period | | 73,305 | | 111,884 | |
Cash and cash equivalents, end of period | | $ | 91,109 | | $ | 114,197 | |
| | | | | |
Supplemental disclosure of cash flow information: | | | | | |
Interest paid | | $ | 5,196 | | $ | 5,591 | |
Income taxes paid, net of refunds | | 216 | | 67 | |
| | | | | |
Supplemental disclosure of non-cash investing and financing activities: | | | | | |
Net book value of assets exchanged | | $ | — | | $ | 52 | |
Capital lease obligations related to the purchase of equipment | | 5,307 | | — | |
Capital lease obligations transferred | | (707 | ) | — | |
Comprehensive loss from hedging transactions, net of taxes | | (862 | ) | 495 | |
Equipment purchases in accounts payable | | 20 | | 1,217 | |
8
ALLIANCE HEALTHCARE SERVICES, INC.
ADJUSTED EBITDA
(in thousands)
Adjusted EBITDA, as defined by the Company’s management, represents net income before: interest expense, net of interest income; income taxes; depreciation expense; amortization expense; net income attributable to noncontrolling interests; non-cash share-based compensation; severance and related costs; loss on extinguishment of debt; fees and expenses related to acquisitions and other non-cash charges included in other income (expense), net, which includes non-cash losses on sales of equipment. The components used to reconcile net income to Adjusted EBITDA are consistent with our historical presentation of Adjusted EBITDA. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles, or “GAAP.”
Management uses Adjusted EBITDA, and believes it is a useful measure for investors, for a variety of reasons. Management regularly communicates its Adjusted EBITDA results and management’s interpretation of such results to its board of directors. Management also compares the Company’s Adjusted EBITDA performance against internal targets as a key factor in determining cash incentive compensation for executives and other employees, largely because management feels that this measure is indicative of how our diagnostic imaging and radiation oncology business is performing and is being managed. Management believes that Adjusted EBITDA is a particularly useful comparative measure within the Company’s industry. The diagnostic imaging and radiation oncology industry continues to experience significant consolidation. These activities have led to significant charges to earnings, such as those resulting from acquisition costs, and to significant variations among companies with respect to capital structures and cost of capital (which affect interest expense) and differences in taxation and book depreciation of facilities and equipment (which affect relative depreciation expense), including significant differences in the depreciable lives of similar assets among various companies. In addition, management believes that because of the variety of equity awards used by companies, the varying methodologies for determining non-cash share-based compensation expense among companies and from period to period, and the subjective assumptions involved in that determination, excluding non-cash share-based compensation from Adjusted EBITDA enhances company-to-company comparisons over multiple fiscal periods and enhances the Company’s ability to analyze the performance of its diagnostic imaging and radiation oncology business.
Adjusted EBITDA may not be directly comparable to similarly titled measures reported by other companies. In addition, Adjusted EBITDA has other limitations as an analytical financial measure. These limitations include the fact that Adjusted EBITDA is calculated before recurring cash charges including interest expense, income taxes and severance costs, and is not adjusted for capital expenditures, the replacement cost of assets or other recurring cash requirements of the Company’s business. Adjusted EBITDA also does not reflect any cost for equity awards to employees. In the future, the Company expects that it may incur expenses similar to the excluded items discussed above. Accordingly, the exclusion of these and other similar items in the Company’s non-GAAP presentation should not be interpreted as implying that these items are non-recurring, infrequent or unusual. Management compensates for the limitations of using Adjusted EBITDA as an analytical measure by relying on the Company’s GAAP results to evaluate its operating performance and by considering independently the economic effects of the items that are or are not reflected in Adjusted EBITDA. Management also compensates for these limitations by providing GAAP-based disclosures concerning the excluded items in the Company’s financial disclosures. As a result of these limitations, however, Adjusted EBITDA should not be considered as an alternative to net income, as calculated in accordance with GAAP, or as an alternative to any other GAAP measure of operating performance.
9
The calculation of Adjusted EBITDA is shown below:
| | First Quarter Ended March 31, | |
| | 2009 | | 2010 | |
Net income attributable to Alliance HealthCare Services, Inc. | | $ | 4,328 | | $ | (2,163 | ) |
Income tax expense (benefit) | | 3,161 | | (613 | ) |
Interest expense and other, net | | 10,677 | | 13,304 | |
Amortization expense | | 2,776 | | 2,806 | |
Depreciation expense | | 23,650 | | 23,691 | |
Share-based payment (included in | | | | | |
selling, general and administrative expenses) | | 1,647 | | 1,506 | |
Noncontrolling interest in subsidiaries | | 654 | | 747 | |
Severance and related costs | | 182 | | 462 | |
Transaction costs | | 431 | | 351 | |
Other non-cash charges (included in other income and expenses, net) | | 327 | | 79 | |
Adjusted EBITDA | | $ | 47,833 | | $ | 40,170 | |
The reconciliation from net income to Adjusted EBITDA for the 2010 guidance range is shown below (in millions):
| | 2010 Full Year
Guidance Range | |
Net (loss) income | | $ | (5 | ) | $ | 5 | |
Income tax (benefit) expense | | (4 | ) | 4 | |
Depreciation expense; amortization expense; interest expense and other, net; noncontrolling interest in subsidiaries; share-based payment and other expenses | | 164 | | 171 | |
Adjusted EBITDA | | $ | 155 | | $ | 180 | |
10
ALLIANCE HEALTHCARE SERVICES, INC.
SELECTED STATISTICAL INFORMATION
| | First Quarter Ended | |
| | March 31, | |
| | 2009 | | 2010 | |
MRI | | | | | |
Average number of total systems | | 285.4 | | 274.3 | |
Average number of scan-based systems | | 242.2 | | 233.1 | |
Scans per system per day (scan-based systems) | | 9.13 | | 8.20 | |
Total number of scan-based MRI scans | | 147,656 | | 122,580 | |
Price per scan | | $ | 380.99 | | $ | 390.32 | |
| | | | | |
Scan-based MRI revenue (in millions) | | $ | 56.3 | | $ | 47.9 | |
Non-scan based MRI revenue (in millions) | | 6.3 | | 5.1 | |
Total MRI revenue (in millions) | | $ | 62.6 | | $ | 53.0 | |
| | | | | |
PET and PET/CT | | | | | |
Average number of systems | | 110.5 | | 119.1 | |
Scans per system per day | | 6.15 | | 5.80 | |
Total number of PET and PET/CT scans | | 45,113 | | 44,231 | |
Price per scan | | $ | 1,116 | | $ | 1,075 | |
| | | | | |
Total PET and PET/CT revenue (in millions) | | $ | 51.0 | | $ | 48.3 | |
| | | | | |
Revenue breakdown (in millions) | | | | | |
Total MRI revenue | | $ | 62.6 | | $ | 53.0 | |
PET and PET/CT revenue | | 51.0 | | 48.3 | |
Radiation oncology revenue | | 8.9 | | 10.8 | |
Other modalities and other revenue | | 9.3 | | 6.6 | |
Total revenues | | $ | 131.8 | | $ | 118.7 | |
| | 2009 | | 2010 | |
Total fixed-site revenue (in millions) | | | | | |
First quarter ended March 31 | | $ | 29.1 | | $ | 27.5 | |
| | | | | | | |
11
ALLIANCE HEALTHCARE SERVICES, INC.
SELECTED STATISTICAL INFORMATION
MRI REVENUE GAP
(in millions)
The Company utilizes the MRI revenue gap as a statistical measure of its MRI client losses and new client contracts. The MRI revenue gap is calculated by measuring the difference between (a) the quarterly MRI revenue run rate lost as a result of clients choosing to terminate contracts with the Company, excluding clients for which Alliance provides interim service and clients that the Company elects to terminate, and (b) projected quarterly new MRI revenue from new client contracts commencing service in the quarter.
The MRI revenue gap for the last eight calendar quarters and the last twelve month period ended March 31, 2010 is as follows:
| | (a) | | (b) | | | |
| | Revenue | | New | | MRI | |
| | Lost | | Revenue | | Revenue Gap | |
2008 | | | | | | | |
Second Quarter | | $ | (9.1 | ) | $ | 4.7 | | $ | (4.4 | ) |
Third Quarter | | (7.0 | ) | 2.2 | | (4.8 | ) |
Fourth Quarter | | (7.7 | ) | 4.0 | | (3.7 | ) |
| | | | | | | |
2009 | | | | | | | |
First Quarter | | (5.7 | ) | 2.3 | | (3.4 | ) |
Second Quarter | | (9.0 | ) | 6.8 | | (2.2 | ) |
Third Quarter | | (12.5 | ) | 4.2 | | (8.3 | ) |
Fourth Quarter | | (12.8 | ) | 7.4 | | (5.4 | ) |
| | | | | | | |
2010 | | | | | | | |
First Quarter | | (7.3 | ) | 5.2 | | (2.1 | ) |
| | | | | | | |
Last Twelve Months Ended March 31, 2010 | | $ | (41.6 | ) | $ | 23.6 | | $ | (18.0 | ) |
12
